About D M Pharma (MKT.) Private Limited
Data last updated:
D M Pharma (MKT.) Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC033864. Its GSTIN is 04AAECD5843M1ZH (Chandigarh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Gautam (Whole-Time Director) and Dinesh Kumar Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S.C.O. 165 1st Floor Sector 38, Chandigarh, India – 160036.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.76 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹27.22 Lakh (net margin 2.5%) and EBITDA of ₹46.71 Lakh (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 19% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.19 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dmpharmachd.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressS.C.O. 165 1st Floor Sector 38, Chandigarh, India – 160036
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of D M Pharma (MKT.) Private Limited
The main business activity of D M Pharma (MKT.) is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of D M Pharma (MKT.) Private Limited
Auditor information for D M Pharma (MKT.) Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of D M Pharma (MKT.) Private Limited
D M Pharma (MKT.) has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar Aggarwal Also directs: Amit Finlease Private Limited | Director | 16 Aug 2018 | 8 Years 1 Months | Current |
| Gautam | Whole-Time Director | 01 Apr 2023 | 3 Years 6 Months | Current |
Financials of D M Pharma (MKT.) Private Limited FY 2024 filings available
D M Pharma (MKT.) Private Limited reported revenue of ₹10.76 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of D M Pharma (MKT.) Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 12% fall in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of D M Pharma (MKT.) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹46.71 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹27.22 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of D M Pharma (MKT.) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of D M Pharma (MKT.) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of D M Pharma (MKT.) Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of D M Pharma (MKT.) Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2022 | Hdfc Bank Limited | ₹20.55 Lakh | Open |
| 20 Jun 2022 | Hdfc Bank Limited | ₹26.37 Lakh | Open |
| 17 May 2021 | Hdfc Bank Limited | ₹1.82 Cr | Open |
| 02 Jan 2014 | Axis Bank Limited | ₹7.6 Lakh | Open |
| 15 Nov 2013 | Axis Bank Limited | ₹1.82 Cr | Open |
Total charge records: 5 View all charges
Employees and EPFO Compliance at D M Pharma (MKT.) Private Limited
D M Pharma (MKT.) Private Limited has a workforce of 12 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of D M Pharma (MKT.) Private Limited
D M Pharma (MKT.) has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECD5843M1ZH | Chandigarh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for D M Pharma (MKT.) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by D M Pharma (MKT.) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of D M Pharma (MKT.) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of D M Pharma (MKT.) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on D M Pharma (MKT.) Private Limited
Frequently Asked Questions about D M Pharma (MKT.) Private Limited
D M Pharma (MKT.) is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2012 (14+ years old) and is registered under CIN U24232CH2012PTC033864.
D M Pharma (MKT.) reported revenue of ₹10.76 Cr for FY 2025 (down 12% YoY).
D M Pharma (MKT.) has 2 current directors:
- Gautam - Whole-Time Director
- Dinesh Kumar Aggarwal - Director
D M Pharma (MKT.) reported a net profit of ₹27.22 Lakh (net margin 2.5%) and EBITDA of ₹46.71 Lakh (EBITDA margin 4.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of D M Pharma (MKT.) is -31% over three years and -19% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of D M Pharma (MKT.) is 04AAECD5843M1ZH, registered in Chandigarh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of D M Pharma (MKT.) is U24232CH2012PTC033864. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D M Pharma (MKT.) was incorporated on 14 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
D M Pharma (MKT.) can be reached through the website dmpharmachd.com. Its registered office is in Chandigarh, India.